THY1 and neoplasm: To screen for other markers of cancer stem cells in PTs, we harvested the BC-P007 xenografted tumor cells for FACS sorting using a panel of markers including CD29, CD44, CD90, CD117, CD 133, CD166, GD2, CD10, CD24 and ALDH.